Does IMDEVIMAB Cause Dyspnoea exertional? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Dyspnoea exertional have been filed in association with IMDEVIMAB. This represents 1.4% of all adverse event reports for IMDEVIMAB.
6
Reports of Dyspnoea exertional with IMDEVIMAB
1.4%
of all IMDEVIMAB reports
1
Deaths
5
Hospitalizations
How Dangerous Is Dyspnoea exertional From IMDEVIMAB?
Of the 6 reports, 1 (16.7%) resulted in death, 5 (83.3%) required hospitalization.
Is Dyspnoea exertional Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IMDEVIMAB. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does IMDEVIMAB Cause?
Infusion related reaction (94)
Dyspnoea (84)
Nausea (48)
Covid-19 pneumonia (42)
Hypoxia (40)
Pyrexia (39)
Oxygen saturation decreased (34)
Vomiting (32)
Dizziness (31)
Cough (27)
What Other Drugs Cause Dyspnoea exertional?
TREPROSTINIL (3,378)
ALBUTEROL (2,190)
MACITENTAN (1,660)
AMBRISENTAN (1,655)
PREDNISONE (1,319)
TIOTROPIUM (1,137)
MEPOLIZUMAB (1,109)
BUDESONIDE\FORMOTEROL (1,038)
OMALIZUMAB (995)
EPOPROSTENOL (938)
Which IMDEVIMAB Alternatives Have Lower Dyspnoea exertional Risk?
IMDEVIMAB vs IMEGLIMIN
IMDEVIMAB vs IMETELSTAT
IMDEVIMAB vs IMIDAPRIL
IMDEVIMAB vs IMIGLUCERASE
IMDEVIMAB vs IMIPENEM